Patents by Inventor Insu P. Lee

Insu P. Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Minari extract for preventing the induction and metastasis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks
    Patent number: 7273625
    Abstract: An extract of the Minari plant containing a component which prevents cancer and cancer metastasis. A Minari extract which is useful for the prevention of cancer and cancer metastasis induced by urethane (EC (ethylcarbamate)), which is a carcinogen present in fermented foods or alcoholic beverages, or by NNK[{(4-N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-buta none)}], which is a carcinogen present in cigarette smoke.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: September 25, 2007
    Inventor: Insu P. Lee
  • Minari extract for preventing the induction and metastasis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks
    Publication number: 20030104089
    Abstract: The present invention relates to an extract of the Minari plant containing a component which prevents cancer and cancer metastasis. More particularly, the present invention relates to a Minari extract which is useful for the prevention of cancer and cancer metastasis induced by urethane (EC (ethylcarbamate)), which is a carcinogen present in fermented foods or alcoholic beverages, or by NNK[{(4-N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-buta none)}], which is a carcinogen present in cigarette smoke.
    Type: Application
    Filed: October 18, 2002
    Publication date: June 5, 2003
    Inventor: Insu P. Lee
  • Methods for treating hyperplasia
    Patent number: 6197808
    Abstract: A method for a treatment of hyperplasia caused by papilloma virus, such as Condyloma acuminata, which comprises concomitantly topically and orally administering at least one tea catechin. Tea catechins do not involve the risk of side-effects and may be easily administered by the patients themselves.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: March 6, 2001
    Assignees: Cancer Instititute (Hospital), Chinese Academy of Medical Sciences, Mitsui Norin Co., Ltd.
    Inventors: Shu Jun Cheng, De Chang Wang, Yukihiko Hara, Insu P. Lee, Woong Shick Ahn